Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipase A and acyltransferase 2 (PLAAT2) is a bifunctional enzyme with both phospholipase and acyltransferase activity, catalyzing the hydrolysis of fatty acids from phospholipids (particularly at sn-1 and sn-2 positions), as well as transferring acyl groups between lipid molecules. PLAAT2 is calcium-independent and can function as a tumor suppressor, regulating cell membrane lipid composition and influencing cell proliferation and survival. It has been implicated in cancer, Poland syndrome, and cystinuria. As a member of the HRASLS family, PLAAT2’s dual enzymatic activities allow it to play a role in lipid metabolism, membrane remodeling, and potentially in cell signaling and apoptosis.
For hypothetical drugs targeting PLAAT2, mechanisms would include inhibition or modulation of its phospholipase or acyltransferase activities, potentially affecting lipid metabolism or phospholipid-mediated signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipase A and acyltransferase 2 (PLAAT2).